The hard-hit Czech Republic has requested a delivery of Russia’s Sputnik V vaccine in response to the delayed arrival of EU-procured jabs and will also consider Chinese inoculations, the president said Sunday.
The EU member tops the world in new infections per 100,000 people over the last 14 days and is second only to neighbouring Slovakia in deaths, according to an AFP tally.
The vaccination rollout is slower than expected with only 650,000 jabs administered since December in the country of 10.7 million people, which Czech politicians blame on slow procurement by the EU.
“After consulting the prime minister, I have sent a letter to (Russian President) Vladimir Putin, asking him for a supply of the Sputnik vaccine,” President Milos Zeman said on TV Prima.
“Information from the Russian embassy suggests it could arrive in the next few days,” said the pro-Russian, pro-Chinese leader.
He said he would not mind if the country used the Chinese Sinopharm vaccine either as “vaccines have no ideology”.
Neither Sputnik V nor Sinopharm have been approved by the European Union regulator EMA, unlike the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford vaccines currently used in the Czech Republic.
But Zeman and Czech Prime Minister Andrej Babis said they would not wait for the EMA to give the green light.
“All we need is a stamp from the (Czech) State Office for Drug Control,” said Babis, who visited Hungary and Serbia earlier this month to learn about the two vaccines.
“Sixty-five countries in the world want the Russian vaccine, including six EU countries, so why say, ‘Jesus, it’s terrible’?” said Babis.
“Believe me when I say that EU member states will also be asking for Sputnik in a few months,” added the billionaire populist, who—like Zeman—has already received both jabs of the Pfizer/BioNTech vaccine.
© 2021 AFP
Hard-hit Czech Republic turns to Russian jabs after EU delays (2021, February 28)
retrieved 28 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.